Aging-Related Metaflammation and Mitochondrial Dysfunction in Neurodegenerative Diseases

Area of Science:

• Neurobiology
• Immunology
• Metabolic Science

Background:

• Neurodegenerative diseases (Alzheimer's, Parkinson's, ALS) are increasingly viewed as systemic aging issues.
• Key factors include metaflammation (metabolic inflammation), mitochondrial dysfunction, and chronic neuroinflammation.
• This systemic dysfunction impacts the brain's immune environment and neuronal integrity.

Purpose of the Study:

• To present a framework linking metaflammation to neurodegeneration across AD, PD, and ALS.
• To explore shared mechanisms driving these interconnected processes.
• To review therapeutic strategies targeting this metabolic-inflammatory axis.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of the interplay between metabolic stress, inflammation, and mitochondrial health.
• Examination of shared pathways in neurodegenerative disease pathogenesis.

Main Results:

• Metaflammation, driven by peripheral metabolic stress, primes the brain via cytokines and blood-brain barrier compromise.
• Metabolic-inflammatory crosstalk impairs mitochondrial function, increasing oxidative stress and inflammation.
• This creates a self-reinforcing cycle of neuroinflammation and energy failure, contributing to neuronal loss.

Conclusions:

• A unified framework connects metaflammation to neurodegeneration, highlighting shared mechanisms in AD, PD, and ALS.
• Therapeutic strategies targeting this axis (e.g., anti-inflammatories, mitophagy enhancers) offer new approaches.
• Interventions focus on systemic metabolic and immune modulation rather than just symptom management.